In a report released yesterday, Erin Wright from Morgan Stanley maintained a Buy rating on Zoetis, with a price target of $211.00.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Erin Wright has given his Buy rating due to a combination of factors that highlight Zoetis’s potential for growth and profitability. Despite recent challenges, such as the lowered 2025 operational revenue guidance and weaker-than-expected performance in the Companion Animal segment, Zoetis’s overall financial health remains robust. The company’s earnings per share exceeded expectations, driven by stronger profitability and favorable tax conditions.
Moreover, Zoetis’s diverse product portfolio and ongoing innovation are seen as significant strengths that differentiate it from competitors. The stock is currently trading at a discount compared to its historical average and peers, which presents an attractive investment opportunity. Wright believes that Zoetis’s exposure to faster-growing and more profitable categories will enhance its market position and drive future growth.
In another report released today, TR | OpenAI – 4o also reiterated a Buy rating on the stock with a $161.00 price target.